Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Indapamide adverse reaction |
Causative agent (attribute) |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Allergy to indapamide |
Causative agent (attribute) |
False |
Indapamide (substance) |
Inferred relationship |
Some |
|
Indapamide 1.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide (substance) |
Inferred relationship |
Some |
|
Indapamide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide (substance) |
Inferred relationship |
Some |
|
Indapamide 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide (substance) |
Inferred relationship |
Some |
|
Perindopril erbumine+indapamide 4mg/1.25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide (substance) |
Inferred relationship |
Some |
|
Product containing indapamide and perindopril (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing indapamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide (substance) |
Inferred relationship |
Some |
|
Allergy to indapamide |
Causative agent (attribute) |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide hemihydrate (substance) |
Is a |
False |
Indapamide (substance) |
Inferred relationship |
Some |
|
Indapamide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide 1.25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely indapamide 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely indapamide 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide 1.25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing indapamide and perindopril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Indapamide hemihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
|
Indapamide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Product containing only indapamide and perindopril (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing only indapamide and perindopril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing only indapamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely indapamide (as indapamide hemihydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Indapamide (substance) |
Inferred relationship |
Some |
1 |
Indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Amlodipine- and indapamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Amlodipine and indapamide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing amlodipine and indapamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Amlodipine and indapamide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 2.5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 2.5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Indapamide 625 microgram and perindopril tosilate 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Indapamide 625 microgram and perindopril tosilate 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely indapamide 625 microgram and perindopril arginine 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely indapamide 625 microgram and perindopril arginine 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Indapamide 2.5 mg and perindopril arginine 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Indapamide 2.5 mg and perindopril arginine 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Product containing amlodipine and indapamide and perindopril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Product containing only amlodipine and indapamide and perindopril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Amlodipine and indapamide and perindopril only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Amlodipine- and indapamide- and perindopril-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and indapamide 1.25 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Amlodipine (as amlodipine besilate) 5 mg and indapamide 2.5 mg and perindopril arginine 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Amlodipine (as amlodipine besilate) 5 mg and indapamide 2.5 mg and perindopril arginine 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and indapamide 2.5 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and indapamide 2.5 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Indapamide (substance) |
Inferred relationship |
Some |
3 |